Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ingevity (NGVT) Cash from Financing Activities (2016 - 2025)

Ingevity (NGVT) has disclosed Cash from Financing Activities for 11 consecutive years, with -$94.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Financing Activities fell 1404.76% to -$94.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$266.4 million, a 1374.64% decrease, with the full-year FY2024 number at -$70.2 million, up 29.73% from a year prior.
  • Cash from Financing Activities was -$94.8 million for Q3 2025 at Ingevity, down from -$63.0 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $313.0 million in Q4 2022 to a low of -$147.0 million in Q2 2022.
  • A 5-year average of -$22.3 million and a median of -$34.5 million in 2023 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: skyrocketed 2545.31% in 2022, then tumbled 1404.76% in 2025.
  • Ingevity's Cash from Financing Activities stood at -$12.8 million in 2021, then surged by 2545.31% to $313.0 million in 2022, then tumbled by 102.08% to -$6.5 million in 2023, then plummeted by 1401.54% to -$97.6 million in 2024, then grew by 2.87% to -$94.8 million in 2025.
  • Per Business Quant, the three most recent readings for NGVT's Cash from Financing Activities are -$94.8 million (Q3 2025), -$63.0 million (Q2 2025), and -$11.0 million (Q1 2025).